Literature DB >> 19444533

Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke.

Oh Young Bang1, Bruce Ovbiagele, David S Liebeskind, Lucas Restrepo, Sa Rah Yoon, Jeffrey L Saver.   

Abstract

BACKGROUND: Although stroke from large vessel atherothromboembolism has a common pathogenesis, its topographic presentation is variable. Given the impact of cerebral infarct size and location on incident stroke magnitude and subsequent prognosis, we evaluated the determinants of cerebral infarct topography among patients with atherosclerotic stroke.
METHODS: We analyzed data on 148 consecutive patients admitted over a 4-year period to a university medical center with acute ischemic stroke within the MCA distribution on DWI, presumed due to atherosclerosis. Based on the DWI data, we divided the patients into three stroke phenotypes: large cortical, small (< 1 cm in diameter) cortical, and deep pattern. Independent factors for each stroke phenotype were evaluated using logistic regression.
RESULTS: After adjusting for covariates, premorbid statin use (OR, 3.05; 95% CI, 1.40-6.65) and older age (OR, 1.05 per 1 year increase; 95% CI, 1.02-1.08) were independently associated with the small cortical phenotypic pattern. In contrast, younger age (OR, 0.95 per 1 year increase; 95% CI, 0.92-0.98), premorbid statin non-use (OR, 0.40; 95% CI, 0.17-0.99), and higher levels of fasting s-glucose (OR, 1.01 per 1 mg/dl increase; 95% CI, 1.00-1.02) and admission peripheral WBC counts (OR, 1.13 per 1 x 10(9) cells/L; 95% CI, 1.00-1.27) were independently associated with the large cortical pattern. There was no relation between DWI patterns and LDL-cholesterol levels.
CONCLUSIONS: Age, premorbid statin use, s-glucose and WBC count predict atherosclerotic stroke phenotype. Further studies should examine whether modifying some of these factors may result in more favorable phenotypic patterns.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444533      PMCID: PMC2745818          DOI: 10.1007/s00415-009-0125-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

1.  Multiple acute stroke syndrome: marker of embolic disease?

Authors:  A E Baird; K O Lövblad; G Schlaug; R R Edelman; S Warach
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

2.  Hyperhomocysteinemia: an independent risk factor for vascular disease.

Authors:  R Clarke; L Daly; K Robinson; E Naughten; S Cahalane; B Fowler; I Graham
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

3.  Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study.

Authors:  C J Weir; G D Murray; A G Dyker; K R Lees
Journal:  BMJ       Date:  1997-05-03

4.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

5.  Atheromatous embolism in the brain: a clinicopathologic analysis of 15 autopsy cases.

Authors:  J Masuda; C Yutani; J Ogata; Y Kuriyama; T Yamaguchi
Journal:  Neurology       Date:  1994-07       Impact factor: 9.910

6.  Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage.

Authors:  S E Akopov; N A Simonian; G S Grigorian
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

Review 7.  Brain embolism, revisited.

Authors:  L R Caplan
Journal:  Neurology       Date:  1993-07       Impact factor: 9.910

8.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.

Authors:  H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

9.  Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke.

Authors:  Pierre Amarenco; A Cohen; M Hommel; T Moulin; D Leys; M-G Bousser
Journal:  N Engl J Med       Date:  1996-05-09       Impact factor: 91.245

10.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  9 in total

1.  Role of statin in atrial fibrillation-related stroke: an angiographic study for collateral flow.

Authors:  Mi Ji Lee; Oh Young Bang; Suk Jae Kim; Gyeong Moon Kim; Chin Sang Chung; Kwang Ho Lee; Bruce Ovbiagele; David S Liebeskind; Jeffrey L Saver
Journal:  Cerebrovasc Dis       Date:  2014-01-16       Impact factor: 2.762

2.  Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome.

Authors:  Y Kaichi; S Kakeda; J Moriya; N Ohnari; K Saito; Y Tanaka; F Tatsugami; S Date; K Awai; Y Korogi
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-25       Impact factor: 3.825

3.  Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?

Authors:  Adrià Arboix; Luis García-Eroles; Montserrat Oliveres; Cecília Targa; Miquel Balcells; Joan Massons
Journal:  BMC Neurol       Date:  2010-06-18       Impact factor: 2.474

4.  The determinants of stroke phenotypes were different from the predictors (CHADS2 and CHA2DS2-VASc) of stroke in patients with atrial fibrillation: a comprehensive approach.

Authors:  Semi Oh; Suk Jae Kim; Soo-Kyoung Ryu; Gyeong-Moon Kim; Chin Sang Chung; Kwang Ho Lee; Oh Young Bang
Journal:  BMC Neurol       Date:  2011-08-24       Impact factor: 2.474

5.  Accessing neuroinflammation sites: Monocyte/neutrophil-mediated drug delivery for cerebral ischemia.

Authors:  Jia Hou; Xu Yang; Shiyi Li; Zhekang Cheng; Yuhua Wang; Jing Zhao; Chun Zhang; Yongji Li; Man Luo; Hongwei Ren; Jianming Liang; Jue Wang; Jianxin Wang; Jing Qin
Journal:  Sci Adv       Date:  2019-07-10       Impact factor: 14.136

6.  Mechanical Thrombectomy for Middle Cerebral Artery Division Occlusions: A Systematic Review and Meta-Analysis.

Authors:  Hisham Salahuddin; Aixa Espinosa; Mark Buehler; Sadik A Khuder; Abdur R Khan; Gretchen Tietjen; Syed Zaidi; Mouhammad A Jumaa
Journal:  Interv Neurol       Date:  2017-08-17

7.  Antioxidant effects of statins in patients with atherosclerotic cerebrovascular disease.

Authors:  Gyeong Joon Moon; Suk Jae Kim; Yeon Hee Cho; Sookyung Ryoo; Oh Young Bang
Journal:  J Clin Neurol       Date:  2014-04-23       Impact factor: 3.077

8.  Mean platelet volume and mean platelet volume/platelet count ratio in nonvalvular atrial fibrillation stroke and large artery atherosclerosis stroke.

Authors:  Ning Zhu; Hao Shu; Wenbing Jiang; Yi Wang; Shunkai Zhang
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

9.  Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study.

Authors:  Shima Shahjouei; Soheil Naderi; Jiang Li; Ayesha Khan; Durgesh Chaudhary; Ghasem Farahmand; Shailesh Male; Christoph Griessenauer; Mirna Sabra; Stefania Mondello; Achille Cernigliaro; Faezeh Khodadadi; Apoorva Dev; Nitin Goyal; Sakineh Ranji-Burachaloo; Oluwaseyi Olulana; Venkatesh Avula; Seyed Amir Ebrahimzadeh; Orkhan Alizada; Mehmet Murat Hancı; Askar Ghorbani; Alaleh Vaghefi Far; Annemarei Ranta; Martin Punter; Mahtab Ramezani; Nima Ostadrahimi; Georgios Tsivgoulis; Paraskevi C Fragkou; Peyman Nowrouzi-Sohrabi; Emmanouil Karofylakis; Sotirios Tsiodras; Saeideh Neshin Aghayari Sheikh; Alia Saberi; Mika Niemelä; Behnam Rezai Jahromi; Ashkan Mowla; Mahsa Mashayekhi; Reza Bavarsad Shahripour; Seyed Aidin Sajedi; Mohammad Ghorbani; Arash Kia; Nasrin Rahimian; Vida Abedi; Ramin Zand
Journal:  EBioMedicine       Date:  2020-08-17       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.